MD1406Z - Метод лечения воспалительных заболеваний пародонта и слизистых оболочек полости рта - Google Patents
Метод лечения воспалительных заболеваний пародонта и слизистых оболочек полости рта Download PDFInfo
- Publication number
- MD1406Z MD1406Z MDS20190050A MDS20190050A MD1406Z MD 1406 Z MD1406 Z MD 1406Z MD S20190050 A MDS20190050 A MD S20190050A MD S20190050 A MDS20190050 A MD S20190050A MD 1406 Z MD1406 Z MD 1406Z
- Authority
- MD
- Moldova
- Prior art keywords
- periodontium
- oral mucosa
- inflammatory diseases
- treating inflammatory
- treatment
- Prior art date
Links
- 210000002200 mouth mucosa Anatomy 0.000 title claims abstract description 10
- 210000004261 periodontium Anatomy 0.000 title claims abstract description 6
- 208000027866 inflammatory disease Diseases 0.000 title claims abstract description 5
- 238000000034 method Methods 0.000 title claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 8
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910000037 hydrogen sulfide Inorganic materials 0.000 claims abstract description 6
- 239000005708 Sodium hypochlorite Substances 0.000 claims abstract description 4
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims abstract description 4
- 210000004877 mucosa Anatomy 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 3
- 239000003814 drug Substances 0.000 abstract description 4
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 210000000214 mouth Anatomy 0.000 description 6
- 208000028169 periodontal disease Diseases 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 206010006326 Breath odour Diseases 0.000 description 4
- 206010018276 Gingival bleeding Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 4
- 208000005888 Periodontal Pocket Diseases 0.000 description 4
- 230000008034 disappearance Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 208000003433 Gingival Pocket Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 201000005562 gingival recession Diseases 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 208000008887 Dental Deposits Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000035154 Hyperesthesia Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010070648 Pyridoxal Kinase Proteins 0.000 description 1
- 102100038517 Pyridoxal kinase Human genes 0.000 description 1
- 208000009596 Tooth Mobility Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000001909 alveolar process Anatomy 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 208000001277 chronic periodontitis Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 description 1
- 229960001625 furazolidone Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000000544 hyperemic effect Effects 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 230000008587 neuronal excitability Effects 0.000 description 1
- QVYRGXJJSLMXQH-UHFFFAOYSA-N orphenadrine Chemical compound C=1C=CC=C(C)C=1C(OCCN(C)C)C1=CC=CC=C1 QVYRGXJJSLMXQH-UHFFFAOYSA-N 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к медицине, в частности к стоматологии и может быть использовано для лечения воспалительных заболеваний пародонта и слизистых оболочек полости рта.Сущность изобретения состоит в том, что проводят зубной детартраж, обрабатывают слизистую оболочку десен тампонами с 1% раствором гипохлорита натрия и 3% перекиси водорода, затем осуществляют полоскание рта с 300…500 мл сульфированной минерализованной водой с концентрацией сероводорода 1,08 мг/л, нагретой до температуры 39…40°C, в течение 5…10 мин, а одновременно назначают per os Магне B6, по 100 мг, 3 раза в день, курс лечения составляет 2…3 недели.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20190050A MD1406Z (ru) | 2019-05-14 | 2019-05-14 | Метод лечения воспалительных заболеваний пародонта и слизистых оболочек полости рта |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20190050A MD1406Z (ru) | 2019-05-14 | 2019-05-14 | Метод лечения воспалительных заболеваний пародонта и слизистых оболочек полости рта |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1406Y MD1406Y (ru) | 2019-12-31 |
| MD1406Z true MD1406Z (ru) | 2020-09-30 |
Family
ID=69057881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20190050A MD1406Z (ru) | 2019-05-14 | 2019-05-14 | Метод лечения воспалительных заболеваний пародонта и слизистых оболочек полости рта |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1406Z (ru) |
-
2019
- 2019-05-14 MD MDS20190050A patent/MD1406Z/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD1406Y (ru) | 2019-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS63132820A (ja) | 口腔用組成物 | |
| RU2550957C1 (ru) | Способ лечения хронического генерализованного пародонтита | |
| RU2470647C1 (ru) | Способ лечения пародонтита | |
| RU2090181C1 (ru) | Лечебно-профилактическая зубная паста "весна" | |
| RU2519121C1 (ru) | Способ лечения пародонтита | |
| RU2162316C1 (ru) | Способ лечения заболеваний пародонта | |
| MD1406Z (ru) | Метод лечения воспалительных заболеваний пародонта и слизистых оболочек полости рта | |
| SU1789214A1 (ru) | Cпocoб лeчehия пapoдohtиta | |
| RU2393893C1 (ru) | Способ коррекции свободнорадикального окисления в ротовой жидкости | |
| RU2661861C1 (ru) | Способ лечения хронической механической травмы слизистой оболочки рта у больных, страдающих сахарным диабетом инсулинозависимого типа | |
| RU2147868C1 (ru) | Способ лечения пародонтита | |
| RU2223088C1 (ru) | Способ лечения воспалительных и воспалительно-деструктивных заболеваний пародонта | |
| RU2158582C1 (ru) | Способ общего лечения пародонтита | |
| RU2201194C2 (ru) | Лекарственная пленка для лечения воспалительных заболеваний пародонта "пиявит" | |
| RU2258546C1 (ru) | Способ подавления патогенной микрофлоры | |
| RU2214217C1 (ru) | Способ лечения пародонтита | |
| RU2693678C1 (ru) | Способ лечения хронического генерализованного пародонтита | |
| RU2549445C1 (ru) | Средство лечения пародонтита и заболеваний слизистой оболочки рта, ассоциированных с геликобактерной инфекцией, и способ его применения | |
| RU2785010C1 (ru) | Способ лечения пародонтита средней степени тяжести у пациентов после перенесенной коронавирусной инфекции | |
| RU2772298C1 (ru) | Способ лечения хронического катарального гингивита с применением антисептической композиции | |
| RU2830816C2 (ru) | Применение фосфолипидной эмульсии, содержащей эффективное количество дигидрокверцетина, лецитин и глицин, для лечения хронических и воспалительных заболеваний полости рта | |
| RU2254859C1 (ru) | Способ лечения пародонтитов | |
| RU2134098C1 (ru) | Способ лечения воспалительных заболеваний пародонта | |
| RU2772293C1 (ru) | Способ лечения хронического афтозного стоматита | |
| RU2429859C1 (ru) | Способ лечения пародонтита |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued | ||
| KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) | ||
| MM4Y | Short-term patent definitely lapsed due to non-payment of fees |